Pregnancy
category N/A Legal status Investigational PubChem CID 170364 Molar mass 546.612 g/mol | ATC code none CAS Number 196808-45-4 IUPHAR/BPS 2672 | |
 | ||
Farglitazar is a peroxisome proliferator-activated receptor agonist which is being developed by GlaxoSmithKline for the treatment of hepatic fibrosis. It is currently in phase II clinical trials.
References
Farglitazar Wikipedia(Text) CC BY-SA